Furthermore, a study published in the Journal of Neuroendocrinology has suggested that the ECS is capable of stimulating specific areas of the body involved in metabolism, such as the skeletal muscles and GI tract. This happens due to the presence of anandamide and 2-AG, which are two naturally-occurring compounds in the body that interact with the CB1 and CB2 receptors.
While overstimulation of the CB1 receptor may lead to symptoms such as high blood pressure and abnormally high cholesterol levels, CBD is a CB1 antagonist, so it is not likely to cause such issues. Furthermore, the World Health Organization has recently issued a global report on CBD, claiming that it has a good safety profile and minimal adverse public health effects.
To briefly review, the endocannabinoid system (ECS) is a group of specialized fatty acid-based signaling chemicals (think “keys”), their receptors (think “locks”), and the metabolic enzymes that produce and break them down. These endocannabinoid chemical signals act on similar brain and immune cell receptors (CB1 and CB2) using the active compounds found in cannabis – cannabidiol (CBD), and Δ9-tetrahydrocannabinol (THC).
Frankel runs GreenBridge Medical, which he founded in 2006, like an internist’s office. He begins with a one-hour consult, comes up with a treatment plan, and recommends products for which he designed the formulas: ten oils with different combinations of THC and CBD. (THC gets you high; CBD doesn’t, but is alleged to have strong healing properties) The #1 oil is almost all CBD, #10 is almost all THC, and #5 has equal amounts of both. So the doctor, patient, and dispensary know how many milligrams of what chemicals the patient is taking, and the doctor can adjust the dose as needed.
Collectively, these results stem from the ability of CBD to induce “fat browning” – that is, converting what is normally white-colored fat tissue (WAT-white adipose tissue) that stores energy to beige-colored fat tissue (BAT-brown and beige adipose tissue) that burns it. Previous studies have shown that boosting beige-colored fat in animals improves their glucose tolerance, making them more resistant to diabetes and various blood lipid abnormalities.
Another marker of obesity and diabetes includes damage to liver cells. The liver is a major organ in the conversion between stored energy forms and useable energy forms in the body. Overburdening that system, such as with high fructose intake, can have disastrous effects. Inflammation within the liver indicates the onset of dysfunction, and possibly non-alcoholic fatty liver disease.
×